First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers
Conditions
Lynch Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Laura Burunat, Barcelona, Barcelona, Spain
Contact: Principal Investigator (Francesc Balaguer, MDPhD)Thomas Walle, MDPhD (Sub-investigator)